Unverricht-Lundborg Progressive Myoclonus Epilepsy in Oman

Pediatric Neurology

Volumn 38, Issue 4, 2008, Pages 252-255

  Santoshkumar, Balagopal ^a   Turnbull, Julie ^b   Minassian, Berge A ^b  

^a ROYAL HOSPITAL   (Oman)

^b HOSPITAL FOR SICK CHILDREN   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BRAIN DYSFUNCTION; CLINICAL ARTICLE; CLINICAL FEATURE; DISEASE COURSE; DISEASE SEVERITY; ELECTROENCEPHALOGRAM; FEMALE; GENE MUTATION; HUMAN; MALE; MYOCLONUS EPILEPSY; OMAN; ONSET AGE; PRIORITY JOURNAL; SCHOOL CHILD;

ADOLESCENT; ADULT; ARABS; CHILD; CHROMOSOMES, HUMAN, PAIR 12; COHORT STUDIES; CYSTATINS; ELECTROENCEPHALOGRAPHY; EVOKED POTENTIALS; FEMALE; HUMANS; MALE; OMAN; PHENOTYPE; RETROSPECTIVE STUDIES; UNVERRICHT-LUNDBORG SYNDROME;

EID: 40749111466     PISSN: 08878994     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pediatrneurol.2007.11.006     Document Type: Article

References (19)

1. Marseille Consensus Group. Classification of progressive myoclonus epilepsies and related disorders. Ann Neurol 28 (1990) 113-116
2. Norio R., and Koskiniemi M. Progressive myoclonus epilepsy: Genetic and nosological aspects with special reference to 107 Finnish patients. Clin Genet 15 (1979) 382-398
3. Lehesjoki A.E., and Koskiniemi M. Progressive myoclonus epilepsy of Unverricht-Lundborg type. Epilepsia 40 Suppl. 3 (1999) 23-28
4. Berkovic S.F., Andermann F., Carpenter S., and Wolfe L.S. Progressive myoclonus epilepsies: Specific causes and diagnosis. N Engl J Med 315 (1986) 296-305
5. Pennacchio L.A., Lehesjoki A.E., Stone N.E., et al. Mutations in the gene encoding cystatin B in progressive myoclonus epilepsy (EPM1). Science 271 (1996) 1731-1734
6. Lafreniere R.G., Rochefort D.L., Chretien N., et al. Unstable insertion in the 5′ flanking region of the cystatin B gene is the most common mutation in progressive myoclonus epilepsy type 1, EPM1. Nat Genet 15 (1997) 298-302
7. Lohi H., Chan E.M., Scherer S.W., and Minassian B.A. On the road to tractability: The current biochemical understanding of progressive myoclonus epilepsies. Adv Neurol 97 (2006) 399-415
8. Berkovic S.F., Mazarib A., Walid S., et al. A new clinical and molecular form of Unverricht-Lundborg disease localised by homozygosity mapping. Brain 128 (2005) 652-658
9. Obeso J.A., Rothwell J.C., and Marsden C.D. The spectrum of cortical myoclonus. Brain 108 (1985) 193-224
10. Lalioti M.D., Scott H.S., Genton P., et al. A PCR amplification method reveals instability the dodecamer repeat in progressive myoclonus epilepsy (EPM1) and no correlation between the size of the repeat and age at onset. Am J Hum Genet 62 (1998) 842-847
11. Koskiniemi M. Psychological findings in progressive myoclonus epilepsy without Lafora bodies. Epilepsia 40 Suppl. 3 (1999) 23-28
12. Lehesjoki A.E. Clinical features and genetic study of Unverricht-Lundborg disease. Adv Neurol 89 (2002) 193-197
13. Ferlazzo E., Magaudda A., Striano P., Hong N.V., Serra S., and Genton P. Long-term evolution of EEG in Unverricht-Lundborg disease. Epilepsy Res 73 (2007) 219-227
14. Mazarib A., Xiong L., Neufeld M.Y., et al. Unverricht-Lundborg disease in a five-generation Arab family. Neurology 57 (2001) 1050-1054
15. Acharya J.N., Satishchandra P., and Shankar S.K. Familial progressive myoclonus epilepsy: Clinical and electrophysiologic observations. Epilepsia 36 (1995) 429-434
16. Sinha S., Satishchandra P., Gayathri N., Yasha T.C., and Sankar S.K. Progressive myolonic epilepsy: A clinical, electrophysiological and pathological study from South India. J Neurol Sci 252 (2007) 16-23
17. Canafoglia L., Ciano C., Panzica F., et al. Sensorimotor cortex excitability in Unverricht-Lundborg disease and Lafora body disease. Neurology 63 (2004) 2309-2315
18. Rajab A., and Patton M.A. A study of consanguinity in the Sultanate of Oman. Ann Hum Biol 27 (2000) 321-326
19. Magaudda A., Ferlazzo E., Nguyen V.H., and Genton P. Unverricht-Lundborg disease, a condition with self-limited progression: Long-term follow up of 20 patients. Epilepsia 47 (2006) 860-866